PMID- 31326514 OWN - NLM STAT- MEDLINE DCOM- 20200828 LR - 20201220 IS - 1878-4216 (Electronic) IS - 0278-5846 (Print) IS - 0278-5846 (Linking) VI - 95 DP - 2019 Dec 20 TI - Examination of pain threshold and neuropeptides in patients with acute suicide risk. PG - 109705 LID - S0278-5846(19)30255-6 [pii] LID - 10.1016/j.pnpbp.2019.109705 [doi] AB - INTRODUCTION: One of the main challenges in suicide prevention is the limited understanding of the biological mechanisms underlying suicide. Recent findings suggest impairments in pain processing in acutely suicidal patients. However, little is known about the biological factors that may drive these discrete physiological abnormalities. In this study, we examined plasma peptides involved in analgesic and inflammatory responses and physical pain threshold in acutely suicidal patients. METHODS: Thirty-seven depressed patients of both sexes hospitalized for severe suicidal ideation or a recent suicide attempt were characterized clinically including history of suicidal ideation and behavior. Psychological and physical pain, and pressure pain threshold was also measured. Plasma levels of beta-endorphin, neurotensin, agouti-related protein (AgRP), C-reactive protein (CRP), adrenocorticotropic hormone (ACTH), and brain-derived neurotrophic factor (BDNF) were run in Milliplex multiplex assays. RESULTS: The number of lifetime suicide attempts was positively correlated with beta-endorphin (r = 0.702; p = 0.007), and neurotensin (r = 0.728, p = 0.007) plasma levels. Higher pain threshold was measured in the suicide attempt group as compared to the suicidal ideation group. Pain threshold was strongly and negatively associated with CRP plasma levels (r = -0.548; p < 0.001). In patients reporting chronic pain, lower AgRP levels and lower pain threshold were observed (t = 4.472; p = 0.001). CONCLUSION: Our results suggest that abnormalities in the opioid and neurotensin systems may underlie the increase in pain threshold found in suicide attempters, and possibly risk for suicidal behavior. Targeting pain circuits and systems may provide therapeutic mechanisms for suicide prevention. CI - Published by Elsevier Inc. FAU - Kim, Diane J AU - Kim DJ AD - Department of Psychiatry and Behavioral Health, Stony Brook University, Stony Brook, New York, USA. FAU - Blossom, Sarah J AU - Blossom SJ AD - Department of Pediatrics and Microbiology/Immunology, University of Arkansas for Medical Sciences, Arkansas Children's Research Institute, Little Rock, AR, USA. FAU - Delgado, Pedro L AU - Delgado PL AD - Psychiatric Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. FAU - Carbajal, Jessica M AU - Carbajal JM AD - Department of Psychiatry and Behavioral Health, Stony Brook University, Stony Brook, New York, USA. FAU - Caceda, Ricardo AU - Caceda R AD - Department of Psychiatry and Behavioral Health, Stony Brook University, Stony Brook, New York, USA. Electronic address: ricardo.caceda@stonybrookmedicine.edu. LA - eng GR - P01 AG012411/AG/NIA NIH HHS/United States GR - P30 GM110702/GM/NIGMS NIH HHS/United States GR - UL1 TR000039/TR/NCATS NIH HHS/United States GR - UL1 TR003107/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20190719 PL - England TA - Prog Neuropsychopharmacol Biol Psychiatry JT - Progress in neuro-psychopharmacology & biological psychiatry JID - 8211617 RN - 39379-15-2 (Neurotensin) RN - 60617-12-1 (beta-Endorphin) SB - IM MH - Adolescent MH - Adult MH - Depressive Disorder/blood/*physiopathology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neurotensin/*blood MH - Pain Measurement MH - Pain Threshold/*physiology MH - *Suicidal Ideation MH - *Suicide, Attempted MH - Young Adult MH - beta-Endorphin/*blood PMC - PMC7309511 MID - NIHMS1599274 OTO - NOTNLM OT - Analgesia OT - Endorphin OT - Neurotensin OT - Pain threshold OT - Peptides OT - Suicide EDAT- 2019/07/22 06:00 MHDA- 2020/08/29 06:00 PMCR- 2020/12/20 CRDT- 2019/07/22 06:00 PHST- 2019/03/27 00:00 [received] PHST- 2019/07/08 00:00 [revised] PHST- 2019/07/17 00:00 [accepted] PHST- 2019/07/22 06:00 [pubmed] PHST- 2020/08/29 06:00 [medline] PHST- 2019/07/22 06:00 [entrez] PHST- 2020/12/20 00:00 [pmc-release] AID - S0278-5846(19)30255-6 [pii] AID - 10.1016/j.pnpbp.2019.109705 [doi] PST - ppublish SO - Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109705. doi: 10.1016/j.pnpbp.2019.109705. Epub 2019 Jul 19.